BSE:539278

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Symbiox Investment & Trading Co

Executive Summary

Symbiox Investment & Trading Co Ltd engages in the trade of sarees in India. More Details


Snowflake Analysis

Adequate balance sheet and fair value.

Share Price & News

How has Symbiox Investment & Trading Co's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 539278 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 539278's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

11.7%

539278

0.4%

IN Retail Distributors

3.0%

IN Market


1 Year Return

228.1%

539278

-6.0%

IN Retail Distributors

13.5%

IN Market

Return vs Industry: 539278 exceeded the Indian Retail Distributors industry which returned -5.6% over the past year.

Return vs Market: 539278 exceeded the Indian Market which returned 11.8% over the past year.


Shareholder returns

539278IndustryMarket
7 Day11.7%0.4%3.0%
30 Day14.1%7.4%12.9%
90 Day16.7%7.1%16.1%
1 Year228.1%228.1%-5.3%-6.0%15.6%13.5%
3 Year-57.1%-57.1%-17.3%-18.9%10.0%4.6%
5 Year-92.4%-92.4%-41.4%-42.4%65.2%52.7%

Long-Term Price Volatility Vs. Market

How volatile is Symbiox Investment & Trading Co's share price compared to the market and industry in the last 5 years?


Simply Wall St News

2 years ago | Simply Wall St

Top Cheap Stocks This Week

2 years ago | Simply Wall St

Cheap BSE Stocks For The Day

Valuation

Is Symbiox Investment & Trading Co undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 539278 (₹1.05) is trading below our estimate of fair value (₹4.37)

Significantly Below Fair Value: 539278 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 539278 is unprofitable, so we can't compare its PE Ratio to the IN Retail Distributors industry average.

PE vs Market: 539278 is unprofitable, so we can't compare its PE Ratio to the Indian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 539278's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 539278 is good value based on its PB Ratio (0.1x) compared to the IN Retail Distributors industry average (0.9x).


Next Steps

Future Growth

How is Symbiox Investment & Trading Co forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

6.6%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Symbiox Investment & Trading Co has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Symbiox Investment & Trading Co performed over the past 5 years?

-45.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 539278 is currently unprofitable.

Growing Profit Margin: 539278 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 539278 is unprofitable, and losses have increased over the past 5 years at a rate of 45.4% per year.

Accelerating Growth: Unable to compare 539278's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 539278 is unprofitable, making it difficult to compare its past year earnings growth to the Retail Distributors industry (-16.4%).


Return on Equity

High ROE: 539278 has a negative Return on Equity (-0.1%), as it is currently unprofitable.


Next Steps

Financial Health

How is Symbiox Investment & Trading Co's financial position?


Financial Position Analysis

Short Term Liabilities: 539278's short term assets (₹314.3M) exceed its short term liabilities (₹2.2M).

Long Term Liabilities: 539278's short term assets (₹314.3M) exceed its long term liabilities (₹2.6M).


Debt to Equity History and Analysis

Debt Level: 539278's debt to equity ratio (0.8%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 539278's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 539278's debt is well covered by operating cash flow (569.9%).

Interest Coverage: Insufficient data to determine if 539278's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is Symbiox Investment & Trading Co current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 539278's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 539278's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 539278's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 539278's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 539278's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average board tenure


CEO

Mahavir Verma (42 yo)

1.67yrs

Tenure

Mr. Mahavir Verma serves as Chairman Symbiox Investment & Trading Co Ltd. and has been its Chief Executive Officer. He has been Whole Time Director of Symbiox Investment & Trading Co. Ltd. since April 22, ...


Board Members

NamePositionTenureCompensationOwnership
Mahavir Verma
Chairman1.67yrsno datano data
Samit Ray
Non-Independent Executive Director1.67yrsno datano data
Ranjit Soni
Non-Executive Independent Director1.33yrsno datano data
Mina Agarwal
Non-Executive Independent Director4.92yrsno datano data
Bappa Mitra
Non-Executive Independent Director1.67yrsno datano data

1.7yrs

Average Tenure

46yo

Average Age

Experienced Board: 539278's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Symbiox Investment & Trading Co Ltd's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Symbiox Investment & Trading Co Ltd
  • Ticker: 539278
  • Exchange: BSE
  • Founded: 1979
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: ₹32.852m
  • Shares outstanding: 31.29m
  • Website: https://www.symbioxinvestment.com

Location

  • Symbiox Investment & Trading Co Ltd
  • 7A, Rani Rashmoni Road
  • Kolkata
  • West Bengal
  • 700013
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
539278BSE (Mumbai Stock Exchange)YesEquity SharesININRAug 2015

Biography

Symbiox Investment & Trading Co Ltd engages in the trade of sarees in India. It also deals in shares, stocks, debentures, bonds, and obligations and securities issued or guarantees; and offers in gunny, he...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/04 12:01
End of Day Share Price2020/12/04 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.